Editor's Corner—Notes on a crazy 2 weeks that transformed immuno-oncology

16th May 2017 Uncategorised 0

It’s been just a couple of weeks since we wrote up AstraZeneca’s Imfinzi approval in bladder cancer. But so much has happened in the immuno-oncology field over that short stretch that, frankly, we at FiercePharma aren’t sure we even recognize the field anymore.

More: Editor's Corner—Notes on a crazy 2 weeks that transformed immuno-oncology
Source: fierce